A haplotype of the angiotensinogen gene is associated with hypertension in African Americans

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 5-6, 2005, Pages 495-502

  Kumar, Ashok ^a   Li, Yanna ^a   Patil, Sai ^a   Jain, Sudhir ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensinogen gene; CCAAT box enhancer binding protein; Glucocorticoid receptor; Haplotype; Human essential hypertension; Molecular genetics; Single nucleotide polymorphism; Transcription

Indexed keywords

AMINO ACID; ANGIOTENSINOGEN; CCAAT ENHANCER BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; METHIONINE; THREONINE; TRANSCRIPTION FACTOR;

ADULT; AFRICAN AMERICAN; AGED; AGT GENE; BLOOD PRESSURE REGULATION; CAUCASIAN; CHINESE; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENE CONSTRUCT; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; VASCULAR DISEASE;

AFRICAN AMERICANS; AGED; ANGIOTENSINOGEN; BASE SEQUENCE; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA;

EID: 20344385579     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04217.x     Document Type: Conference Paper

References (46)

1. Luft FC. Hypertension as a complex genetic trait. Semin. Nephrol. 2002; 22: 115-26.
2. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104: 545-56.
3. Krushkal J, Ferrell R, Mockrin SC et al. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 1999; 99: 1407-10.
4. Hunt SC, Ellison RC, Atwood LD et al. Genome scans for blood pressure and hypertension: The National Heart, Lung, and Blood Institute Family Heart Study. Hypertension 2002; 40: 1-6.
5. Kristjansson K, Manolescu A, Kristinsson A et al. Linkage of essential hypertension to chromosome 18q. Hypertension 2002; 39: 1044-9.
6. Rice T, Rankinen T, Chagnon YC et al. Genomewide linkage scan of resting blood pressure: HERITAGE Family Study. Health, Risk Factors, Exercise Training, and Genetics. Hypertension 2002; 39: 1037-43.
7. Levy D, DeStefano AL, Larson MG et al. Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study. Hypertension 2000; 36: 477-83.
8. Caulfield M, Munroe P, Pembroke J et al. Genome-wide mapping of human loci for essential hypertension. Lancet 2003; 361: 2118-23.
9. Kageyama R, Ohkubo H, Nakanishi S. Primary structure of human preangiotensinogen deduced from the cloned cDNA sequence. Biochemistry 1984; 23: 3603-9.
10. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: Role of angiotensinogen. Endocr. Rev. 1997; 18: 662-77.
11. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc. Res. 1971; 5: 86-9.
12. Fasola AF, Martz BL, Helmer OM. Renin activity during supine exercise in normotensives and hypertensives. J. Appl. Physiol. 1966; 21: 1709-12.
13. Watt GC, Harrap SB, Foy CJ et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four-corners approach to the identification of genetic determinants of blood pressure. J. Hypertens. 1992; 10: 473-82.
14. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 1986; 78: 31-9.
15. Kimura S, Mullins JJ, Bunnemann B et al. High blood pressure in transgenic mice carrying the rat angiotens inogen gene. EMBO J. 1992; 11: 821-7.
16. Tanimoto K, Sugiyama F, Goto Y et al. Angiotensinogen-deficient mice with hypotension. J. Biol. Chem. 1994; 269: 31 334-7.
17. Kim HS, Krege JH, Kluckman KD et al. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl Acad. Sci. USA 1995; 92: 2735-9.
18. Krege JH, Kim HS, Moyer JS et al. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 1997; 29: 150-7.
19. Jeunemaitre X, Soubrier F, Kotelevtsev YV et al. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169-80.
20. Inoue I, Nakajima T, Williams CS et al. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 1997; 99: 1786-97.
21. Walker WG, Whelton PK, Saito H et al. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1:287-91.
22. Bloem LJ, Foroud TM, Ambrosius WT et al. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997; 29: 1078-82.
23. Caulfield M, Lavender P, Newell Price J et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J. Clin. Invest. 1995; 96: 687-92.
24. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35: 1297-300.
25. Wu SJ, Chiang FT, Chen WJ et al. Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: Single locus genotype vs. haplotype analysis. Physiol. Genomics 2004; 17: 79-86.
26. Choy B, Roberts SG, Griffin LA et al. How eukaryotic transcription activators increase assembly of preinitiation complexes. Cold Spring Harb. Symp. Quant. Biol. 1993; 58: 199-203.
27. Choy B, Green MR. Eukaryotic activators function during multiple steps of preinitiation complex assembly. Nature 1993; 366: 531-6.
28. Ptashne M. Albert Lasker Award for Basic Medical Research. Control of gene transcription: An outline. Nat. Med. 1997; 3: 1069-72.
29. LeVan TD, Bloom JW, Bailey TJ et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 2001; 167: 5838-44.
30. Spek CA, Greengard JS, Griffin JH et al. Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J. Biol. Chem. 1995; 270: 24216-21.
31. Farzaneh-Far A, Davies JD, Braam LA et al. A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J. Biol. Chem. 2001; 276: 32 466-73.
32. Narayanan CS, Cui Y, Kumar A. DBP binds to the proximal promoter and regulates liver-specific expression of the human angiotensinogen gene. Biochem. Biophys. Res. Commun. 1998; 251: 388-93.
33. Zhao YY, Zhou J, Narayanan CS et al. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 1999; 33: 108-15.
34. Narayanan CS, Cui Y, Zhao YY et al. Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity. Mol. Cell. Endocrinol 1999; 148: 79-86.
35. Yanai K, Nibu Y, Murakami K et al. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J. Biol. Chem. 1996; 271: 15 981-6.
36. Cui Y, Narayanan CS, Zhou J et al. Exon-T is involved in positive as well as negative regulation of human angiotensinogen gene expression. Gene 1998; 224: 97-107.
37. Sherman CT, Brasier AR. Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol. Endocrinol. 2001; 15: 441-57.
38. Narayanan CS, Cui Y, Kumar S et al. cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor. Mol. Cell. Biochem. 2000; 212: 81-90.
39. Matsuno F, Chowdhury S, Gotoh T et al. Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes. J. Biochem. 1996; 119: 524-32.
40. Zhang Z, Jones S, Hagood JS et al. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 1997; 272: 30 607-10.
41. Brasier AR, Han Y, Sherman CT. Transcriptional regulation of angiotensinogen gene expression. Vitam. Horm. 1999; 57: 217-47.
42. Jain S, Tang X, Narayanan CS et al. Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J. Biol. Chem. 2002; 277: 36 889-96.
43. Ron D, Brasier AR, Wright KA et al. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol. Cell. Biol. 1990; 10: 4389-95.
44. Ron D, Brasier AR, Wright KA et al. An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol. Cell. Biol. 1990; 10: 1023-32.
45. Jeunemaitre X, Inoue I, Williams C et al. Haplotypes of angiotensinogen in essential hypertension. Am. J. Hum. Genet. 1997; 60: 1448-60.
46. Ray RB, Meyer K, Ray R. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 2000; 271: 197-204.